PDCD1 and nonpapillary renal cell carcinoma: Studies have found that immune inhibitors such as LAG3 [27, 52], BTLA [27], PD-1 (PDCD1) [52], and CTLA-4 [52], or immunostimulators like TNFSF13B [57] play important roles in ccRCC.